Next Article in Journal
Development of a Ternary Solid Dispersion Formulation of LW6 to Improve the In Vivo Activity as a BCRP Inhibitor: Preparation and In Vitro/In Vivo Characterization
Previous Article in Journal
Advantages and Limitations of Integrated Flagellin Adjuvants for HIV-Based Nanoparticle B-Cell Vaccines
 
 
Article

Article Versions Notes

Pharmaceutics 2019, 11(5), 205; https://doi.org/10.3390/pharmaceutics11050205
Action Date Notes Link
article xml file uploaded 1 May 2019 09:55 CEST Original file -
article xml uploaded. 1 May 2019 09:55 CEST Update -
article pdf uploaded. 1 May 2019 09:55 CEST Version of Record https://www.mdpi.com/1999-4923/11/5/205/pdf-vor
article html file updated 1 May 2019 09:57 CEST Original file -
article pdf uploaded. 22 May 2019 12:50 CEST Updated version of record https://www.mdpi.com/1999-4923/11/5/205/pdf
article xml uploaded. 22 May 2019 12:50 CEST Update -
article xml uploaded. 22 May 2019 12:50 CEST Update https://www.mdpi.com/1999-4923/11/5/205/xml
article html file updated 23 May 2019 11:16 CEST Update -
article html file updated 23 May 2019 11:16 CEST Update -
article html file updated 4 June 2019 23:31 CEST Update -
article html file updated 19 October 2019 09:21 CEST Update -
article html file updated 12 February 2020 09:17 CET Update -
article html file updated 19 July 2022 18:07 CEST Update https://www.mdpi.com/1999-4923/11/5/205/html
Back to TopTop